294 related articles for article (PubMed ID: 33167306)
1. Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.
Granados K; Poelchen J; Novak D; Utikal J
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167306
[TBL] [Abstract][Full Text] [Related]
2. Melanoma Progression Inhibits Pluripotency and Differentiation of Melanoma-Derived iPSCs Produces Cells with Neural-like Mixed Dysplastic Phenotype.
Castro-Pérez E; Rodríguez CI; Mikheil D; Siddique S; McCarthy A; Newton MA; Setaluri V
Stem Cell Reports; 2019 Jul; 13(1):177-192. PubMed ID: 31231022
[TBL] [Abstract][Full Text] [Related]
3. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J
Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613
[TBL] [Abstract][Full Text] [Related]
4. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
[TBL] [Abstract][Full Text] [Related]
6. Linking Pluripotency Reprogramming and Cancer.
Iglesias JM; Gumuzio J; Martin AG
Stem Cells Transl Med; 2017 Feb; 6(2):335-339. PubMed ID: 28191771
[TBL] [Abstract][Full Text] [Related]
7. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.
Peretz Y; Wu H; Patel S; Bellacosa A; Katz RA
PLoS One; 2015; 10(2):e0116839. PubMed ID: 25642713
[TBL] [Abstract][Full Text] [Related]
9. Microenvironment-derived factors driving metastatic plasticity in melanoma.
Kim IS; Heilmann S; Kansler ER; Zhang Y; Zimmer M; Ratnakumar K; Bowman RL; Simon-Vermot T; Fennell M; Garippa R; Lu L; Lee W; Hollmann T; Xavier JB; White RM
Nat Commun; 2017 Feb; 8():14343. PubMed ID: 28181494
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression.
Wang Y; Mou Y; Zhang H; Wang X; Li R; Cheng Z; Liu X
Int J Med Sci; 2017; 14(13):1402-1409. PubMed ID: 29200954
[TBL] [Abstract][Full Text] [Related]
11. Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage "Switch" Phenotype.
Malyshev I; Malyshev Y
Biomed Res Int; 2015; 2015():341308. PubMed ID: 26366410
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications.
Massi D; Mihic-Probst D; Schadendorf D; Dummer R; Mandalà M
Cancer Treat Rev; 2020 Aug; 88():102060. PubMed ID: 32619863
[TBL] [Abstract][Full Text] [Related]
13. Geometric regulation of histone state directs melanoma reprogramming.
Lee J; Molley TG; Seward CH; Abdeen AA; Zhang H; Wang X; Gandhi H; Yang JL; Gaus K; Kilian KA
Commun Biol; 2020 Jul; 3(1):341. PubMed ID: 32620903
[TBL] [Abstract][Full Text] [Related]
14. The Role of microRNAs in Animal Cell Reprogramming.
Cruz-Santos MC; Aragón-Raygoza A; Espinal-Centeno A; Arteaga-Vázquez M; Cruz-Hernández A; Bako L; Cruz-Ramírez A
Stem Cells Dev; 2016 Jul; 25(14):1035-49. PubMed ID: 27224014
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.
Doherty RE; Sisley K; Hammond DW; Rennie IG; Cross NA
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5387-5395. PubMed ID: 29049740
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
17. Phenotype switching through epigenetic conversion.
Brevini TA; Pennarossa G; Maffei S; Gandolfi F
Reprod Fertil Dev; 2015 Jun; 27(5):776-83. PubMed ID: 25739562
[TBL] [Abstract][Full Text] [Related]
18. RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment.
Čermák V; Škarková A; Merta L; Kolomazníková V; Palušová V; Uldrijan S; Rösel D; Brábek J
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802847
[TBL] [Abstract][Full Text] [Related]
19. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of Melanoma with Stem Cell Properties.
Seftor EA; Margaryan NV; Seftor REB; Hendrix MJC
Adv Exp Med Biol; 2019; 1139():105-114. PubMed ID: 31134497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
